Cargando…
Myositis with prominent B-cell aggregates causing shrinking lung syndrome in systemic lupus erythematosus: a case report
BACKGROUND: Shrinking lung syndrome (SLS) is a rare manifestation of systemic lupus erythematosus (SLE) characterized by decreased lung volumes and diaphragmatic weakness in a dyspneic patient. Chest wall dysfunction secondary to pleuritis is the most commonly proposed cause. In this case report, we...
Autores principales: | Roy, Flavie, Korathanakhun, Pat, Karamchandani, Jason, Dubé, Bruno-Pierre, Landon-Cardinal, Océane, Routhier, Nathalie, Peyronnard, Caroline, Massie, Rami, Leclair, Valérie, Meyer, Alain, Bourré-Tessier, Josiane, Satoh, Minoru, Fritzler, Marvin J., Senécal, Jean-Luc, Hudson, Marie, O’Ferrall, Erin K., Troyanov, Yves, Ellezam, Benjamin, Makhzoum, Jean-Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848966/ https://www.ncbi.nlm.nih.gov/pubmed/35168668 http://dx.doi.org/10.1186/s41927-021-00240-0 |
Ejemplares similares
-
Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype
por: Troyanov, Yves, et al.
Publicado: (2017) -
Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients
por: Meyer, Alain, et al.
Publicado: (2020) -
Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis
por: Giannini, Margherita, et al.
Publicado: (2023) -
Statin-associated anti-HMGCR immune-mediated necrotizing myopathy with dermatomyositis-like features: A case report
por: Lim, Darosa, et al.
Publicado: (2020) -
Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies
por: Landon-Cardinal, Océane, et al.
Publicado: (2020)